Tower Research Capital (TRC)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,554
| Closed | -$1.08M | – | 6488 |
|
|
2023
Q2 | $1.08M | Buy |
27,554
+22,710
| +469% | +$802K | 0.04% | 465 |
|
|
2023
Q1 | $118K | Buy |
4,844
+3,465
| +251% | +$75.9K | ﹤0.01% | 1715 |
|
|
2022
Q4 | $30K | Sell |
1,379
-7,316
| -84% | -$156K | ﹤0.01% | 2763 |
|
|
2022
Q3 | $156K | Sell |
8,695
-26,311
| -75% | -$345K | ﹤0.01% | 2163 |
|
|
2022
Q2 | $337K | Buy |
35,006
+30,035
| +604% | +$377K | 0.01% | 1396 |
|
|
2022
Q1 | $84K | Sell |
4,971
-9,940
| -67% | -$147K | ﹤0.01% | 2347 |
|
|
2021
Q4 | $249K | Sell |
14,911
-24,224
| -62% | -$397K | ﹤0.01% | 1600 |
|
|
2021
Q3 | $636K | Buy |
39,135
+32,962
| +534% | +$359K | 0.02% | 823 |
|
|
2021
Q2 | $39K | Buy |
6,173
+2,913
| +89% | +$18.8K | ﹤0.01% | 3248 |
|
|
2021
Q1 | $21K | Sell |
3,260
-1,665
| -34% | -$10.1K | ﹤0.01% | 3861 |
|
|
2020
Q4 | $34K | Sell |
4,925
-45,160
| -90% | -$289K | ﹤0.01% | 3481 |
|
|
2020
Q3 | $282K | Buy |
50,085
+47,848
| +2,139% | +$228K | ﹤0.01% | 2235 |
|
|
2020
Q2 | $11K | Buy |
2,237
+23
| +1% | +$96 | ﹤0.01% | 3985 |
|
|
2020
Q1 | $8K | Sell |
2,214
-16,168
| -88% | -$94.5K | ﹤0.01% | 2147 |
|
|
2019
Q4 | $158K | Buy |
18,382
+18,229
| +11,914% | +$65.1K | 0.01% | 701 |
|
|
2019
Q3 | $0 | Buy |
+153
| New | +$178 | ﹤0.01% | 4655 |
|
|
2019
Q2 | – | Sell |
-500
| Closed | -$1K | – | 4494 |
|
|
2019
Q1 | $1K | Sell |
500
-19,050
| -97% | -$26.6K | ﹤0.01% | 3660 |
|
|
2018
Q4 | $24K | Buy |
19,550
+6,601
| +51% | +$12.8K | ﹤0.01% | 1806 |
|
|
2018
Q3 | $30K | Buy |
+12,949
| New | +$32.3K | ﹤0.01% | 2079 |
|
|
2018
Q1 | – | Sell |
-1,288
| Closed | -$4K | – | 4008 |
|
|
2017
Q4 | $4K | Sell |
1,288
-810
| -39% | -$2.28K | ﹤0.01% | 3023 |
|
|
2017
Q3 | $6K | Sell |
2,098
-9,001
| -81% | -$24.3K | ﹤0.01% | 3276 |
|
|
2017
Q2 | $28K | Buy |
+11,099
| New | +$30.2K | ﹤0.01% | 1047 |
|
|
2017
Q1 | – | Sell |
-6,340
| Closed | -$30K | – | 4133 |
|
|
2016
Q4 | $30K | Buy |
6,340
+5,434
| +600% | +$161K | ﹤0.01% | 1796 |
|
|
2016
Q3 | $42K | Buy |
+906
| New | +$51.1K | ﹤0.01% | 1238 |
|
|
2016
Q2 | – | Sell |
-47
| Closed | -$2K | – | 5143 |
|
|
2016
Q1 | $2K | Buy |
+47
| New | +$2.4K | ﹤0.01% | 3483 |
|
|
2015
Q2 | – | Sell |
-2,625
| Closed | -$122K | – | 5193 |
|
|
2015
Q1 | $122K | Buy |
+2,625
| New | +$136K | 0.02% | 738 |
|
|
2014
Q4 | – | Sell |
-1
| Closed | – | – | 4871 |
|
|
2014
Q3 | $0 | Sell |
1
-223
| -100% | -$8.75K | ﹤0.01% | 5009 |
|
|
2014
Q2 | $9K | Sell |
224
-542
| -71% | -$19.9K | ﹤0.01% | 2466 |
|
|
2014
Q1 | $27K | Buy |
+766
| New | +$25.8K | ﹤0.01% | 1616 |
|
Tower Research Capital (TRC)'s ISEE Position: Q3 2023 in Review
Tower Research Capital (TRC) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 27,554 shares — an estimated $1.08M sold.
Tower Research Capital (TRC) first reported a position in ISEE in Q1 2014 and held it in 29 quarters. The position peaked at $1.08M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Tower Research Capital (TRC) reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 27,554 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.08M.
- Tower Research Capital (TRC) first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 29 quarters.
- Tower Research Capital (TRC)'s IVERIC bio, Inc. Common Stock position peaked at $1.08M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.